JPRN-UMIN000027216Not yet recruiting未知
Phase II study of nab-paclitaxel combined with S-1 in patients with early breast cancer:A multicenter clinical trial - nab-paclitaxel + S-1 for early breast cancer
The University of Tokushima Graduate School0 sites80 target enrollmentStarted: May 8, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1)DCIS or breast cancer wiht micro invasion. (2)Patients with contraindication for any agents necessary in the planned treatment (3)Male (4)Women who are pregnant, lactating or with childbearing potential. (5)Patients with a history of chemotherapy, endocrinetherapy or radiotherapy. (6)Multiple primary cancer. (7)Serious complications(diabetes infection or mental disorder) (8)Serious complications with cardiac function (9)Patients with serious edema (10)Hypersensitivity to any agents necessary in the planned treatment. (11)Ineligible based on decision of a investigator.
Investigators
Similar Trials
Completed
Phase 2
Phase II study of Nab-paclitaxel plus S-1 followed by FEC as neoadjuvant chemotherapy for the operable breast cancerbreast cancerJPRN-UMIN000017177Kitasato University Kitasato Institute Hospital28
Completed
Not Applicable
A Phase I/II study of nab-Paclitaxel plus S-1 therapy in previously treated patients with refractory advanced non-small-cell lung cancerJPRN-UMIN000012966Depatment of Thoracic Oncology Osaka Medical Center for Cancer and Cardiovascular Diseases45
Recruiting
Phase 2
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22
Completed
Phase 2
Phase II study of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000035812Kyoto Prefectural University of Medicine45
Completed
Not Applicable
A phase II study of nab-paclitaxel for pretreated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012972Kanagawa Cancer Center30